Wolverine Trading, LLC Alaunos Therapeutics, Inc. Call Options Transaction History

Wolverine Trading, LLC

$94.2 Billion
Q2 2024

Call Options

24 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 15, 2023	BUY	$0.12 - $0.5 $1,116 - $4,650	9,300 Added 56.71%	25,700 $3,000
Q2 2023 Aug 23, 2023	SELL	$0.43 - $0.65 $3,569 - $5,395	-8,300 Reduced 33.6%	16,400 $8,000
Q1 2023 May 15, 2023	SELL	$0.46 - $0.81 $37,306 - $65,691	-81,100 Reduced 76.65%	24,700 $16,000
Q4 2022 Feb 14, 2023	SELL	$0.5 - $261.0 $2,250 - $1.17 Million	-4,500 Reduced 4.08%	105,800 $69,000
Q3 2022 Nov 14, 2022	BUY	$1.04 - $322.5 $60,840 - $18.9 Million	58,500 Added 112.93%	110,300 $218,000
Q2 2022 Aug 15, 2022	BUY	$0.41 - $1.24 $11,398 - $34,472	27,800 Added 115.83%	51,800 $64,000
Q1 2022 May 16, 2022	SELL	$0.62 - $1.17 $36,890 - $69,615	-59,500 Reduced 71.26%	24,000 $16,000
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.89 $91,015 - $157,815	83,500 New	83,500 $94,000
Q3 2021 Nov 12, 2021	SELL	$1.44 - $2.73 $78,192 - $148,239	-54,300 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$2.63 - $3.67 $172,528 - $240,752	-65,600 Reduced 54.71%	54,300 $146,000
Q1 2021 May 14, 2021	BUY	$2.82 - $5.6 $217,422 - $431,760	77,100 Added 180.14%	119,900 $404,000
Q4 2020 Feb 12, 2021	SELL	$2.09 - $3.09 $18,183 - $26,883	-8,700 Reduced 16.89%	42,800 $113,000
Q3 2020 Nov 13, 2020	SELL	$2.39 - $3.43 $117,827 - $169,099	-49,300 Reduced 48.91%	51,500 $132,000
Q2 2020 Aug 13, 2020	SELL	$2.2 - $3.71 $103,840 - $175,112	-47,200 Reduced 31.89%	100,800 $324,000
Q1 2020 May 11, 2020	BUY	$1.9 - $4.98 $73,720 - $193,224	38,800 Added 35.53%	148,000 $377,000
Q4 2019 Feb 12, 2020	SELL	$3.95 - $5.35 $163,530 - $221,489	-41,400 Reduced 27.49%	109,200 $523,000
Q3 2019 Nov 14, 2019	BUY	$4.13 - $6.94 $126,791 - $213,058	30,700 Added 25.6%	150,600 $636,000
Q2 2019 Aug 20, 2019	SELL	$3.98 - $6.2 $208,552 - $324,880	-52,400 Reduced 30.41%	119,900 $699,000
Q1 2019 May 15, 2019	SELL	$2.0 - $4.4 $26,200 - $57,640	-13,100 Reduced 7.07%	172,300 $663,000
Q4 2018 Feb 14, 2019	BUY	$1.61 - $3.62 $298,494 - $671,148	185,400 New	185,400 $308,000
Q3 2018 Nov 14, 2018	SELL	$2.26 - $3.27 $127,463 - $184,428	-56,400 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$3.46 - $5.14 $16,954 - $25,186	-4,900 Reduced 7.99%	56,400 $221,000
Q4 2017 Feb 14, 2018	BUY	$4.0 - $6.54 $60,800 - $99,408	15,200 Added 32.97%	61,300 $254,000
Q3 2017 Nov 15, 2017	BUY	$4.99 - $6.57 $230,039 - $302,877	46,100	46,100 $283,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account